Low-frequency pulsed electromagnetic field therapy in fibromyalgia: A randomized, double-blind, sham-controlled clinical study

Clinical Journal of Pain

Volumn 25, Issue 8, 2009, Pages 722-728

  Sutbeyaz, Serap Tomruk ^a,b   Sezer, Nebahat ^a   Koseoglu, Fusun ^a   Kibar, Sibel ^a  

^a ANKARA PHYSICAL MEDICINE AND REHABILITATION EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Karakusunlar M 339 ^*  (Turkey)

Author keywords

Chronic pain; Fibromyalgia syndrome; Pulsed electromagnetic fields; Randomized clinical trial

Indexed keywords

ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EMOTION; EVALUATION; FATIGUE; FEMALE; FIBROMYALGIA; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; MUSCLE STIFFNESS; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL CAPACITY; PHYSIOTHERAPY; PRIORITY JOURNAL; PULSED ELECTROMAGNETIC FIELD THERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SOCIAL INTERACTION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WAKEFULNESS; WORK DISABILITY;

EID: 70349658210     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181a68a6c     Document Type: Article

References (39)

1. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:1-18.
2. Wolfe F, Ross K, Anderson J, et al. The prevalance and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
3. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol. 2005;75(suppl 75):6-21.
4. Eisinger J, Gandolfo C, Zakarian H, et al. Reactive oxygen species, antioxidant status, and fibromyalgia. J Musculoskelet Pain. 1997;5:5-15.
5. Leventhal LJ. Management of fibromyalgia. Ann Intern Med. 1999;131:856-858.
6. Mease PJ, Clauw DJ, Arnold LM, et al. Fibromyalgia Syndrome. J Rheumatol. 2005;32:2270-2277.
7. Heckman JD, Ingram AJ, Loyd RD, et al. Nonunion treatment with pulsed electromagnetic fields. Clin Orthop Relat Res. 1981;161:58-66.
8. Bassett CA, Pilla AA, Pawluk RJ. A non-operative salvage of surgically-resistant pseudarthroses and non-unions by pulsing electromagnetic fields. A preliminary report. Clin Orthop Relat Res. 1977;124:128-143.
9. Bassett CA, Schink-Ascani M. Long-term pulsed electromagnetic field (PEMF) results in congenital pseudarthrosis. Calcif Tissue Int. 1991;49:216-220.
10. Ganguly KS, Sarkar AK, Datta AK, et al. A study of the effects of pulsed electromagnetic field therapy with respect to serological grouping in rheumatoid arthritis. J Indian Med Assoc. 1998;96:272-275.
11. Pipitone N, Scott DL. Magnetic pulse treatment for knee osteoarthritis: a randomized, double-blind, placebo-controlled study. Curr Med Res Opin. 2001;17:190-196.
12. Trock DH. Electromagnetic fields and magnets. Investigational treatment for musculoskeletal disorders. Rheum Dis Clin North Am. 2000;26:51-62.
13. Binder A, Parr G, Hazleman B, et al. Pulsed electromagnetic field therapy of persistent rotator cuff tendonitis. A doubleblind controlled assessment. Lancet. 1984;1:695-698.
14. Thumm S, Loschinger M, Glock S, et al. Induction of cAMPdependent protein kinase A activity in human skin fibroblasts and rat osteoblasts by extremely low-frequency electromagnetic fields. Radiat Environ Biophys. 1999;38:195-199.
15. Pezzeti F, De-Mattei M, Caruso A, et al. Effects of pulsed electromagnetic fields on human chondrocytes: an in vitro study. Calcif Tissue Int. 1999;65:396-401.
16. Goodman R, Wei LX, Xu JC, et al. Exposure of human cells to low-frequency electromagnetic fields results in quantitative changes in transcripts. Biochim Biophys Acta. 1989;1009: 216-220.
17. Kim SS, Shin HJ, Eom DW, et al. Enhanced expression of neuronal nitric oxide synthase and phospholipase C-g1 in regenerating murine neuronal cells by pulsed electromagnetic field. Exp Mol Med. 2002;34:53-59.
18. Staud R. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol. 2004;16:157-163.
19. Thomas AW, Kavaliers M, Prato FS, et al. Antinociceptive effects of a pulsed magnetic field in the land snail, Cepaea nemoralis. Neurosci Lett. 1997;222:107-110.
20. Shupak NM, Prato FS, Thomas AW. Human exposure to a specific pulsed magnetic field: effects on thermal sensory and pain thresholds. Neurosci Lett. 2004;363:157-162.
21. Sartucci F, Bonfiglio L, Del Seppia C, et al. Changes in pain perception and pain-related somatosensory evoked potentials in humans produced by exposure to oscillating magnetic field. Brain Res. 1997;769:362-366. (Pubitemid 27461473)
22. Shupak NM, McKay JC, Nielson WR, et al. Exposure to a specific pulsed low-frequency magnetic field: a double-blind placebo-controlled study of effects on pain ratings in rheumatoid arthritis and fibromyalgia patients. Pain Res Manag. 2006;11:85-90.
23. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.
24. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9-12.
25. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728-733.
26. Huskisson EC. Measurement of pain. Lancet. 1974;2:1127-1131.
27. Mccormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988; 18:1007-1119.
28. Beck AT, Ster RA, Garbin MG. Psychometric properties of beck depression inventory: 25 years of evaluation. Clin Psychol Rev. 1988;8:77-100.
29. Hisli N. Beck depresyon envanterinin üniversite öq́ rencileri için geçerliliq́ i ve güvenilirliq́ i. Turk Psikoloji Dergisi. 1989;7:313.
30. Jenkinson C, Coulter A, Wright L. Short form 36 (SF-36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306:1437-1440.
31. Ware JE, Keller SD, Hatoun HT, et al. The SF-36 Arthritis Specific Health Index (ASHI): I. Development and cross validation of scoring algorithms. Med Care. 1999;37:MS40-MS50.
32. Dundar P, Fidaner C, Fidaner H. Comparing the Turkish versions of WHOQOL-BREF and SF-36, convergen+velidity of WHOQOL-BREF and SF-36. Hippokratic. 2002;6:37-43.
33. Altan L, Bingol U, Aykac M, et al. Investigation of the effects of pool-based exercise on fibromyalgia syndrome. Rheumatol Int. 2004;24:272-277.
34. Dunkl PR, Taylor AG, McConnel GG, et al. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol. 2000;27:2683-2691.
35. Shupak NM, Prato FS, Thomas AW. Therapeutic uses of pulsed magnetic field exposure: a review. Radio Sci Bull. 2003;307:9-32.
36. Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose. Curr Pharm Des. 2006; 12:3-9.
37. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
38. Anderberg UM,Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study. Eur J Pain. 2000;4:27-35.
39. Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007; 8(suppl 2):S63-S74.